Next Article in Journal
Transcriptomics Analysis on Excellent Meat Quality Traits of Skeletal Muscles of the Chinese Indigenous Min Pig Compared with the Large White Breed
Next Article in Special Issue
Molecular Epidemiology and Evolution of European Bat Lyssavirus 2
Previous Article in Journal
Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Previous Article in Special Issue
Phylodynamic and Genetic Diversity of Canine Parvovirus Type 2c in Taiwan
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(1), 23;

Hepatitis C Virus: Viral Quasispecies and Genotypes

Joint Faculty of Veterinary Meedicine, Kagoshima University, 1-21-24 Korimoto Kagoshima-city, Kgoshima 890-0065, Japan
Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute, 2-1-6 Kamikitazawa, Setagaya-Ku 156-8506, Japan
Author to whom correspondence should be addressed.
Received: 6 December 2017 / Revised: 16 December 2017 / Accepted: 18 December 2017 / Published: 22 December 2017
(This article belongs to the Special Issue Virus Comparative Genomics)
Full-Text   |   PDF [1072 KB, uploaded 22 December 2017]   |  


Hepatitis C virus (HCV) mainly replicates in the cytoplasm, where it easily establishes persistent infection, resulting in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Due to its high rate of mutation, HCV forms viral quasispecies, categorized based on the highly variable regions in the envelope protein and nonstructural 5A protein. HCV possesses seven major genotypes, among which genotype 1 is the most prevalent globally. The distribution of HCV genotypes varies based on geography, and each genotype has a different sensitivity to interferon treatment. Recently-developed direct-acting antivirals (DAAs), which target viral proteases or polymerases, mediate drastically better antiviral effects than previous therapeutics. Although treatment with DAAs has led to the development of drug-resistant HCV mutants, the most recently approved DAAs show improved pan-genomic activity, with a higher barrier to viral resistance. View Full-Text
Keywords: hepatitis C virus; quasispecies; genotype; interferon therapy; direct-acting antivirals; resistant mutation hepatitis C virus; quasispecies; genotype; interferon therapy; direct-acting antivirals; resistant mutation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

  • Externally hosted supplementary file 1
    Doi: non
    Link: http://non
    Description: Revised manuscript with track change

Share & Cite This Article

MDPI and ACS Style

Tsukiyama-Kohara, K.; Kohara, M. Hepatitis C Virus: Viral Quasispecies and Genotypes. Int. J. Mol. Sci. 2018, 19, 23.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top